PCR fingerprinting:: a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans

被引:35
作者
Meyer, W [1 ]
Maszewska, K [1 ]
Sorrell, TC [1 ]
机构
[1] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Mol Mycol Lab, Sydney, NSW 2006, Australia
关键词
Candida albicans; Candida dubliniensis; identification; PCR fingerprinting;
D O I
10.1080/714031016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Candida dubliniensis was recently identified as a germ-tube- and chlamydospore-positive yeast, phenotypically and morphologically indistinguishable from the phylogenetically closely related yeast species C. albicans and its synonymized variant C. stellatoidea. The high similarity between these yeast species causes significant problems in the correct identification of C. dubliniensis in a standard clinical mycology laboratory, Polymerase chain reaction (PCR) fingerprinting was successfully applied here to distinguish between clinical isolates of the two closely related species. Microsatellite ([GACA](4)) and minisatellite ([5'-GAGGGTGGCGGTTCT-3'], derived from the core-sequence of the wild-type phage M13) specific oligonucleotides were used as single primers in PCR to amplify hypervariable inter-repeat DNA sequences from 16 C. dubliniensis strains and 11 C, albicans strains. Each species, represented by its ex-type strain, could be identified by a distinct species-specific multilocus pattern, allowing identification to species level for all clinical isolates. In addition, the PCR fingerprinting generated strain-specific profiles, making this method applicable to epidemiological investigations. PCR fingerprinting using the primer M13 is proposed here as a simple, reliable and highly reproducible molecular tool to differentiate between strains of C. albicans and C, dubliniensis.
引用
收藏
页码:185 / 193
页数:9
相关论文
共 30 条
[1]  
ALI S, 1986, HUM GENET, V74, P239
[2]  
*APPL MATHS BVBA, 1999, GELC 2 VERS 1 01
[3]   CLUSTER OF ORAL ATYPICAL CANDIDA-ALBICANS ISOLATES IN A GROUP OF HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE DRUG-USERS [J].
BOERLIN, P ;
BOERLINPETZOLD, F ;
DURUSSEL, C ;
ADDO, M ;
PAGANI, JL ;
CHAVE, JP ;
BILLE, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) :1129-1135
[4]  
Coleman D, 1997, Oral Dis, V3 Suppl 1, pS96
[5]   Candidiasis: The emergence of a novel species, Candida dubliniensis [J].
Coleman, DC ;
Sullivan, DJ ;
Bennett, DE ;
Moran, GP ;
Barry, HJ ;
Shanley, DB .
AIDS, 1997, 11 (05) :557-567
[6]   Candida dubliniensis:: phylogeny and putative virulence factors [J].
Gilfillan, GD ;
Sullivan, DJ ;
Haynes, K ;
Parkinson, T ;
Coleman, DC ;
Gow, NAR .
MICROBIOLOGY-SGM, 1998, 144 :829-838
[7]   Identification of Candida dubliniensis in a prospective study of patients in the United States [J].
Jabra-Rizk, MA ;
Baqui, AAMA ;
Kelley, JI ;
Falkler, WA ;
Merz, WG ;
Meiller, TF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (02) :321-326
[8]   Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis [J].
Joly, S ;
Pujol, C ;
Rysz, M ;
Vargas, K ;
Soll, DR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :1035-1044
[9]   Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C-albicans [J].
Kurzai, O ;
Heinz, WJ ;
Sullivan, DJ ;
Coleman, DC ;
Frosch, M ;
Mühlschegel, FA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1587-1590
[10]  
KWONCHUNG KJ, 1989, INFECT IMMUN, V57, P627